WST * Stock Overview Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details
Rewards Risk Analysis See All Risk Checks {"enabled":false,"variant":{"name":"disabled","enabled":false},"ready":false,"error":null}
Capture your thoughts, links and company narrative
West Pharmaceutical Services, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for West Pharmaceutical Services Historical stock prices Current Share Price US$7,059.69 52 Week High US$7,104.95 52 Week Low US$5,692.00 Beta 1 1 Month Change n/a 3 Month Change n/a 1 Year Change n/a 3 Year Change -11.32% 5 Year Change n/a Change since IPO -14.71%
Recent News & Updates
Third quarter dividend of US$0.21 announced Feb 04
West Pharmaceutical Services, Inc. to Report Q4, 2024 Results on Feb 13, 2025 Jan 30
West Pharmaceutical Services, Inc. Announces Dividend for the First-Quarter of 2025, Payable on February 11, 2025 Jan 29
West Pharmaceutical Services, Inc. Introduces Daikyo PLASCAP RUV Closures in New Nested Format At Pharmapack Jan 22
West Pharmaceutical Services, Inc Elects Janet Haugen as New Director to the Board Dec 11
Insider recently sold Mex$1.4m worth of stock Nov 03 See more updates
Third quarter dividend of US$0.21 announced Feb 04
West Pharmaceutical Services, Inc. to Report Q4, 2024 Results on Feb 13, 2025 Jan 30
West Pharmaceutical Services, Inc. Announces Dividend for the First-Quarter of 2025, Payable on February 11, 2025 Jan 29
West Pharmaceutical Services, Inc. Introduces Daikyo PLASCAP RUV Closures in New Nested Format At Pharmapack Jan 22
West Pharmaceutical Services, Inc Elects Janet Haugen as New Director to the Board Dec 11
Insider recently sold Mex$1.4m worth of stock Nov 03
Third quarter dividend of US$0.21 announced Nov 01
Insufficient new directors Nov 01 West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2024 West Pharmaceutical Services, Inc. to Report Q3, 2024 Results on Oct 24, 2024 Oct 10
West Pharmaceutical Services, Inc. Announces Resignation of Silji Abraham as Senior Vice President & Chief Technology Officer, Effective December 31, 2024 Oct 08
Insufficient new directors Sep 11
Second quarter 2024 earnings released: EPS: US$1.53 (vs US$2.09 in 2Q 2023) Jul 26
Upcoming dividend of US$0.20 per share Jul 24
West Pharmaceutical Services, Inc. to Report Q2, 2024 Results on Jul 25, 2024 Jul 12
Senior VP & CTO recently sold Mex$11m worth of stock Jun 14
First quarter dividend of US$0.20 announced Jun 13
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy May 30
Dividend of US$0.20 announced May 07
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc Apr 28 West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024
West Pharmaceutical Services, Inc. to Report Q1, 2024 Results on Apr 25, 2024 Apr 12
West Pharmaceutical Services, Inc., Annual General Meeting, Apr 23, 2024 Mar 14
West Pharmaceutical Services, Inc. Announces Second Quarter 2024 Dividend, Payable on May 1, 2024 Feb 20
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Full Year 2024 Feb 15
West Pharmaceutical Services, Inc. to Report Q4, 2023 Results on Feb 15, 2024 Feb 02
Upcoming dividend of US$0.20 per share at 0.2% yield Jan 24
West Pharmaceutical Services, Inc. Announces Dividend for the First Quarter of 2024, Payable on February 7, 2024 Dec 06 West Pharmaceutical Services, Inc. Receives FDA 510(K) Clearance for Vial2bag Advanced 13mm Admixture Device Dec 05
West Pharmaceutical Services, Inc. Approves Fourth-Quarter 2023 Dividend, Payable on November 15, 2023
West Pharmaceutical Services, Inc. to Report Q3, 2023 Results on Oct 26, 2023 Oct 13
West Pharmaceutical Services, Inc. Revises Earnings Guidance for the Full-Year 2023 Jul 29
Second quarter 2023 earnings released: EPS: US$2.09 (vs US$2.53 in 2Q 2022) Jul 28
Upcoming dividend of US$0.19 per share at 0.2% yield Jul 18
West Pharmaceutical Services, Inc. to Report Q2, 2023 Results on Jul 27, 2023 Jul 14
Upcoming dividend of US$0.19 per share at 0.2% yield Apr 18
Investor sentiment improves as stock rises 18% Apr 13
Investor sentiment deteriorates as stock falls 17% Feb 23
Full year 2022 earnings released: EPS: US$7.88 (vs US$8.90 in FY 2021) Feb 22 West Pharmaceutical Services, Inc. (NYSE:WST) announces an Equity Buyback for $1,000 million worth of its shares.
West Pharmaceutical Services, Inc. to Report Q4, 2022 Results on Feb 16, 2023 Feb 03
West Pharmaceutical Services, Inc. Approves First-Quarter 2023 Dividend, Payable on February 1, 2023 Dec 14 West Pharmaceutical Services, Inc. Updating Full-Year 2022 Guidance
West Pharmaceutical Services, Inc. to Report Q3, 2022 Results on Oct 27, 2022 Oct 14
Investor sentiment deteriorated over the past week Aug 13
Key Executive recently sold Mex$99m worth of stock Aug 04
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Full Year 2022 Jul 29
Second quarter 2022 earnings released: EPS: US$2.53 (vs US$2.53 in 2Q 2021) Jul 28
West Pharmaceutical Services, Inc. Elects Stephen Lockhart as New Director to the Board Jul 28
West Pharmaceutical Services, Inc. to Report Q2, 2022 Results on Jul 28, 2022 Jul 15
Upcoming dividend of US$0.18 per share Jul 12
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith 2.25mL Insert Needle Syringe System At BIO International Convention Jun 14
West Pharmaceutical Services, Inc. Announces Executive Leadership Appointments May 13
West Pharmaceutical Services, Inc. to Report Q1, 2022 Results on Apr 28, 2022 Apr 15 West Pharmaceutical Services, Inc. Announces Board Changes
West Pharmaceutical Services, Inc. Announces Second-Quarter 2022 Dividend, Payable on May 4, 2022 Feb 24
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 19 West Pharmaceutical Services, Inc. Announces Asset Impairment for the Fourth Quarter Ended December 31, 2021
West Pharmaceutical Services, Inc. to Report Q4, 2021 Results on Feb 17, 2022 Feb 04
Upcoming dividend of US$0.18 per share Jan 11
Insufficient new directors Aug 11 Shareholder Returns WST * MX Life Sciences MX Market 7D 0% 0% 0% 1Y n/a 0% 0%
See full shareholder returns
Return vs Market: Insufficient data to determine how WST * performed against the MX Market .
Price Volatility Is WST *'s price volatile compared to industry and market? WST * volatility WST * Average Weekly Movement n/a Life Sciences Industry Average Movement 0% Market Average Movement 0% 10% most volatile stocks in MX Market 0% 10% least volatile stocks in MX Market 0%
Stable Share Price: WST *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine WST *'s volatility change over the past year.
About the Company West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
Show more West Pharmaceutical Services, Inc. Fundamentals Summary How do West Pharmaceutical Services's earnings and revenue compare to its market cap? WST * fundamental statistics Market cap Mex$484.22b Earnings (TTM ) Mex$10.31b Revenue (TTM ) Mex$59.33b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) WST * income statement (TTM ) Revenue US$2.88b Cost of Revenue US$1.87b Gross Profit US$1.00b Other Expenses US$503.40m Earnings US$499.60m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
Earnings per share (EPS) 6.90 Gross Margin 34.87% Net Profit Margin 17.37% Debt/Equity Ratio 7.4%
How did WST * perform over the long term?
See historical performance and comparison Dividends
0.3% Current Dividend Yield When do you need to buy WST * by to receive an upcoming dividend? West Pharmaceutical Services dividend dates Ex Dividend Date Feb 07 2025 Dividend Pay Date Feb 11 2025 Days until Ex dividend 5 days Days until Dividend pay date 1 day
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/11 11:33 End of Day Share Price 2025/01/31 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources West Pharmaceutical Services, Inc. is covered by 29 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Ishan Majumdar Baptista Research Lawrence Marsh Barclays Derik de Bruin BofA Global Research
Show 26 more analysts 